EOM Pharmaceutical Holdings News

EOM Pharmaceutical Holdings Provides an Update on Its Lead Drug Candidate EOM613

MONTVALE, N.J., Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613. EOM613 is a pep

PR NewswireNov 7, 2023 20:00

EOM Pharmaceutical Holdings Announces Topline Results of Its COVID-19 Clinical Trial of EOM613 in Brazil

Results indicate that EOM613 treatment mitigates cytokine release in patients with COVID-19 pulmonary vascular inflammation MONTVALE, N.J., Sept. 6, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings,

PR NewswireSep 6, 2023 19:00

IPO Roundup: Richtech Robotics, Triller and More

Seeking AlphaAug 7, 2023 20:47

EOM Pharmaceuticals Shelves Plans to Uplist Shares, Raise $15M

Seeking AlphaAug 4, 2023 06:01

EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.

Company to continue trading on the OTC Markets under the ticker symbol "IMUC" while pursuing listing on a national exchange MONTVALE, N.J., Nov. 10, 2022 /PRNewswire/ -- EOM Pharmaceutical Holdings,

PR NewswireNov 10, 2022 23:10

EOM Pharmaceuticals files to uplist to Nasdaq

EOM Pharmaceuticals (OTCPK:IMUC) has filed to uplist from the Pink Sheets to the Nasdaq. As part of the application, EOM would trade on the Nasdaq under the ticker "EOM." EOM (formerly ImmunoCellular

Seeking AlphaJun 25, 2022 05:08

Press Release: EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement

EOM Pharmaceuticals, Inc. And Immunocellular Therapeutics, Ltd. Announce Entry Into And Close Of Definitive Merger Agreement Combined company will operate as EOM Pharmaceuticals Holdings, Inc.

Dow Jones NewswiresDec 2, 2021 21:10

ImmunoCellular Therapeutics L, Inst Holders, 3Q 2019 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 3Q 2019 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended September 3

道琼斯Oct 22, 2019 15:53

ImmunoCellular Therapeutics L, Inst Holders, 2Q 2019 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 2Q 2019 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended June 30, 20

道琼斯Jul 22, 2019 15:59

ImmunoCellular Therapeutics L, Inst Holders, 1Q 2019 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 1Q 2019 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended March 31, 2

道琼斯Apr 23, 2019 15:56

ImmunoCellular Therapeutics L, Inst Holders, 4Q 2018 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 4Q 2018 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended December 31

道琼斯Jan 22, 2019 17:09

DJ ImmunoCellular Therapeutics L, Inst Holders, 3Q 2018 (IMUC)

DJ ImmunoCellular Therapeutics L, Inst Holders, 3Q 2018 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended September 3

道琼斯Oct 22, 2018 15:25

DJ ImmunoCellular Therapeutics Ltd. (IMUC) Halted

DJ ImmunoCellular Therapeutics Ltd. (IMUC) Halted (END) Dow Jones Newswires October 16, 2018 12:28 ET (16:28 GMT) Copyright (c) 2018 Dow Jones & Company, Inc.

道琼斯Oct 17, 2018 00:28

BRIEF-Immunocellular Therapeutics Ltd - Anthony Gringeri Resigs From Board And As President And CEO Of Co

Oct 15 (Reuters) - ImmunoCellular Therapeutics Ltd :   * IMMUNOCELLULAR THERAPEUTICS LTD - ANTHONY GRINGERI NOTIFIED CO HE RESIGNED FROM BOARD AND AS PRESIDENT AND CEO OF CO, EFFECTIVE AS OF OC

路透社Oct 16, 2018 05:06

DJ ImmunoCellular Files 8K - Director, Officer or Compensation Filing >IMUC

DJ ImmunoCellular Files 8K - Director, Officer or Compensation Filing >IMUC ImmunoCellular Therapeutics Ltd. (IMUC) filed a Form 8K - Director, Officer or Compensation Filing - with the U.S

道琼斯Oct 16, 2018 04:35

*DJ ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stk and Listed Common Stk Warrants

Press Release: ImmunoCellular Therapeutics Announces Delisting and Deregistration of Common Stock and Listed Common Stock Warrants ImmunoCellular Therapeutics Announces Delisting and Deregistrat

道琼斯Oct 16, 2018 04:09

BRIEF-ImmunoCellular Therapeutics Says Has Been Exploring Strategic Opportunities

Aug 13 (Reuters) - ImmunoCellular Therapeutics Ltd :   * IMMUNOCELLULAR THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS   * Q2 LOSS PER SHARE $0.01  

路透社Aug 14, 2018 04:15

Press Release: ImmunoCellular Therapeutics -2-

*DJ ImmunoCellular 2Q Loss/Shr 1c >IMUC (MORE TO FOLLOW) Dow Jones Newswires (212-416-2800) August 13, 2018 16:05 ET (20:05 GMT) Press Release: ImmunoCellular Therapeutics Provides Cor

道琼斯Aug 14, 2018 04:05

*DJ ImmunoCellular 2Q Loss/Shr 1c >IMUC

*DJ ImmunoCellular 2Q Loss/Shr 1c >IMUC (MORE TO FOLLOW) Dow Jones Newswires (212-416-2800) August 13, 2018 16:05 ET (20:05 GMT) Copyright (c) 2018 Dow Jones & Company, Inc.

道琼斯Aug 14, 2018 04:05

DJ ImmunoCellular Therapeutics Ltd, Inst Holders, 2Q 2018 (IMUC)

DJ ImmunoCellular Therapeutics Ltd, Inst Holders, 2Q 2018 (IMUC) The following table shows the largest shareholders in IMMUNOCELLULAR THERAPEUTICS LTD CO (IMUC) for the quarter ended June 30,

道琼斯Jul 22, 2018 07:40